Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Sep;32(9):1172-1177.
doi: 10.1111/iju.70117. Epub 2025 May 15.

Research Landscape on Adrenocortical Carcinoma Over Four Decades

Affiliations
Review

Research Landscape on Adrenocortical Carcinoma Over Four Decades

Tun-Pang Chu et al. Int J Urol. 2025 Sep.

Abstract

Objectives: Adrenocortical carcinoma is a rare but devastating endocrine malignancy. Our objective was to outline the academic output and trends through bibliometric analysis.

Methods: We searched the Web of Science Core Collection, PubMed, and Scopus to retrieve publications related to adrenocortical carcinoma using the structured three-step PRISMA methodology. Co-authorship and co-occurrence analyses were conducted to visualize collaborative and thematic networks.

Results: This overview comprises 5507 documents. The number of publications on adrenocortical carcinoma has consistently increased over time. Most of these publications originate from North America and Europe. The co-occurrence map identified several major research clusters, with immunotherapy and targeted therapy emerging as new treatment modalities in recent years. The number of co-authoring institutions per publication was positively correlated with citation counts (Spearman's rank coefficient = 0.17, p < 0.0001).

Conclusions: This literature analysis provides an overview of the current research landscape on adrenocortical carcinoma, highlighting geographical disparities. International and interdisciplinary collaboration may enhance productivity and foster scientific progress.

Keywords: Scopus; adrenocortical carcinoma; bibliometric analysis; web of science.

PubMed Disclaimer

References

    1. T. Chandrasekar, H. Goldberg, Z. Klaassen, et al., “The Who, When, and Why of Primary Adrenal Malignancies: Insights Into the Epidemiology of a Rare Clinical Entity,” Cancer 125, no. 7 (2019): 1050–1059, https://doi.org/10.1002/cncr.31916.
    1. W. H. Tsai, S. H. Dai, C. C. Lee, M. N. Chien, and Y. H. Zeng, “A Clinicopathological Analysis of Asian Patients With Adrenocortical Carcinoma: A Single‐Center Experience,” Current Oncology 30, no. 4 (2023): 4117–4125, https://doi.org/10.3390/curroncol30040313.
    1. J. Pedersen, A. E. Jarlov, A. K. Rasmussen, and K. Stochholm, “Incidence, Treatment, and Survival of Adrenocortical Carcinoma in Denmark 2003–2019,” Journal of the Endocrine Society 8, no. 3 (2024): bvae012, https://doi.org/10.1210/jendso/bvae012.
    1. C. H. Tsai, T. S. Huang, and S. P. Cheng, “Trends in the Incidence of Adrenocortical Carcinoma and Pheochromocytoma/Paraganglioma in Taiwan,” Formosan Journal of Surgery 56, no. 5 (2023): 147–152, https://doi.org/10.1097/FS9.0000000000000072.
    1. C. H. Tsai, T. P. Liu, and S. P. Cheng, “Academic Characterization of the Formosan Journal of Surgery: A Five‐Year Bibliometric Analysis,” Formosan Journal of Surgery 58, no. 2 (2025): 84–85, https://doi.org/10.1097/FS9.0000000000000162.

MeSH terms

LinkOut - more resources